Collaboration and co-development

At Biocrine we focus on discovery and validation of novel drugable targets and drugs in the field of diabetes and its complications. We highly acknowledge scientific collaborations with academia for these targets and co-development, partnering or licensing with biotechnology and pharmaceutical companies. Advantages in partnering with Biocrine include

• Access to novel validated diabetes targets and compounds
• Access to Biocrines in-vivo technology offering significant development and validation advantages

InSight technology services

We also provide access to our InSight technology through service agreements for organizations with research or development projects in other fields than diabetes that benefit from in-vivo studies of molecular processes in a cell.

To find out more about the technology, please follow the link here.

 

To get in touch with us, please write to info@biocrine.se